This inventor holds 2 USPTO granted patents. Top assignees: Newtree Industry Co., Ltd., Other. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 2 
2 out of 834,570 Years Active: 2014
Title: Innovations of Jae-Youn Chung: Pioneering Lignan Compounds for Health
Introduction: Jae-Youn Chung is a prominent inventor based in Seoul, South Korea, known for his innovative contributions in the field of pharmaceutical compounds. With a total of two patents to his name, Chung has made significant strides in addressing inflammatory diseases and acne treatment through his research on lignan compounds.
Latest Patents: Jae-Youn Chung's latest patents are focused on utilizing lignan compounds for therapeutic purposes. The first patent discusses the use of lignan compounds to treat or prevent inflammatory diseases. It describes a method by which macelignan, a specific lignan compound, can inhibit inflammatory reactions by targeting various mediators such as NO, iNOS, PGE, COX-2, and TNF-α. This innovative approach holds promise for effectively treating inflammatory diseases in vivo.
The second patent revolves around a method and composition aimed at treating acne using lignan compounds. This invention highlights an antibacterial composition designed to combat acne-causing bacteria, showcasing the antibacterial activity of lignan compounds and their thermal stability. Chung's work in this area presents a valuable option for acne treatment agents.
Career Highlights: Over his career, Jae-Youn Chung has actively contributed to the advancement of pharmaceutical innovations. His tenure at Newtree Industry Co., Ltd. has been instrumental in the research and development of applications for lignan compounds. Through his inventive work, he has gained recognition for advancing treatments that harness the potential of natural compounds in medicine.
Collaborations: Jae-Youn Chung has collaborated with notable colleagues, including Jae-Kwan Hwang and Hee-Chul Chung, who have helped advance his research initiatives. These collaborations have fostered an environment of shared expertise, enhancing the development and potential applications of lignan-based therapies.
Conclusion: Jae-Youn Chung's innovative work in the field of lignan compounds is setting new standards in the treatment of inflammatory diseases and acne. His contributions not only demonstrate his dedication as an inventor but also represent significant advancements in the pharmaceutical landscape. The implications of his patents offer hope for improved therapeutic options in managing these prevalent health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile